Tests hyperbaric oxygen therapy in people recovering from acute ischemic stroke
Tests oxygen therapy in a pressure chamber for adults recovering from stroke.
Plain-language title generated from the registry record
Registry title: Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
Key facts
- Where
- New Orleans, United StatesSee the site
Where in United States
- Touro Infirmary New OrleansNew Orleans, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- LCMC Health
- Trial code
- NCT06148285
- Record updated
- 28 November 2023
- Original description
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.Read full original descriptionShow less
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Recovery
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.
Inclusion: Age 18 years and above; Ischemic stroke proven on neuroimaging; Within 7-30 days post-stroke on day 1 of treatment; Admitted to Touro Inpatient Rehab Facility.
Exclusion: Pre-stroke modified Rankin Scale Score >2; History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures; Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids); Parenchymal hemorrhagic transformation (PH1 or PH2); Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed.